🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested
The primary aim of this observational study is to collect safety and effect...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00440479
Treatments Being Tested
The purpose of the study is to determine outcomes for Multiple Myeloma pati...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-04-20
Trial ID
NCT05271630
Treatments Being Tested
This is a Phase 1 clinical trial examining the safety, pharmacokinetics and...
Status
Completed
Location
Mater Adult Hospital
Start Date
2007-07
Trial ID
NCT00629473
The purpose of the study is to evaluate whether single-agent Elranatamab (P...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2021-02-02
Trial ID
NCT04649359
Treatments Being Tested
The clinical trial is a Phase II open label, single-arm pilot study to eval...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2015-11-01
Trial ID
NCT02474927
Treatments Being Tested
This study is researching a drug called linvoseltamab (also called "study d...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2026-01-02
Trial ID
NCT07222761
Treatments Being Tested